Close Menu

UCSF

Sangamo Therapeutics has announced preliminary results from its gene-editing trial, the Associated Press reports.

Cancer Research UK has awarded nearly £60 million in funding to three US investigator-led research initiatives focused on cancer progression and drug response.

In Cell this week: approach for mapping enhancers and their targets, comparative protein interaction analysis of dengue and Zika viruses, and more.

Second X Helping

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.

In Cell this week: gene editing-based strategy to screen for immune system regulators, ancient plague patterns, and more.

The US Department of Health and Human Services says it has not cancelled a fetal tissue contract with a University of California, San Francisco, lab, Science reports.

The funding is being provided to a number of early-career investigators and collaborative research groups using genomics and other technologies.

The US National Institutes of Health is sending tissue chips to space to study physiological changes that astronauts undergo in microgravity.

Prospective research suggests DNA and RNA sequencing can reveal pathogen, microbiome, and host expression features to detect lower respiratory tract infections.

Pages

A letter criticizing actions by the US government and research institutions toward Chinese and Chinese-American scientists has garnered more than a hundred signatories.

NPR reports that researchers in New York are investigating whether it is possible to edit the genomes of human sperm.

In an opinion piece at the Nation, Sarah Lawrence College's Laura Hercher argues that everyone should be able to access prenatal genetic testing.

In Nature this week: ancient DNA uncovers presence of Mediterranean migrants at a Himalayan lake, and more.